Long-term clinical outcome after postchemotherapy retroperitoneal lymph node dissection in men with residual teratoma Academic Article uri icon

Overview

MeSH Major

  • Antineoplastic Agents
  • Lymph Node Excision
  • Retroperitoneal Neoplasms
  • Teratoma
  • Testicular Neoplasms

abstract

  • PC-RPLND remains critical in the management of patients with NSGCT. Patients found to have teratoma at PC-RPLND have a 10-year probability of freedom from recurrence of 80%. The size of the residual mass and IGCCCG risk classification were significant predictors of disease recurrence.

publication date

  • March 20, 2007

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1200/JCO.2005.05.4791

PubMed ID

  • 17261854

Additional Document Info

start page

  • 1033

end page

  • 7

volume

  • 25

number

  • 9